Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1,261.00
-143.00 (-10.19%)
Apr 29, 2025, 5:32 PM IDT
TLV:REKA Revenue
In the year 2024, Rekah Pharmaceutical Industry had annual revenue of 321.71M ILS with 0.02% growth. Rekah Pharmaceutical Industry had revenue of 76.16M in the quarter ending December 31, 2024, a decrease of -11.49%.
Revenue
321.71M
Revenue Growth
+0.02%
P/S Ratio
0.46
Revenue / Employee
764.16K
Employees
421
Market Cap
146.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 321.71M | 49.00K | 0.02% |
| Dec 31, 2023 | 321.66M | 29.27M | 10.01% |
| Dec 31, 2022 | 292.39M | 28.44M | 10.78% |
| Dec 31, 2021 | 263.95M | -1.52M | -0.57% |
| Dec 31, 2020 | 265.47M | 68.97M | 35.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 920.37M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |